| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J2778 |
Injection, ranibizumab, 0.1 mg |
1,977 |
1,393 |
$963K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
238 |
213 |
$340K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
4,258 |
3,846 |
$289K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
4,873 |
4,194 |
$250K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,253 |
1,183 |
$193K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
2,926 |
2,397 |
$163K |
| 92060 |
|
2,933 |
2,686 |
$155K |
| 92134 |
|
4,433 |
3,690 |
$90K |
| 92083 |
|
1,553 |
1,397 |
$50K |
| 92015 |
Determination of refractive state |
2,222 |
2,065 |
$38K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
313 |
286 |
$28K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
426 |
369 |
$22K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
252 |
228 |
$19K |
| 92133 |
|
887 |
804 |
$17K |
| 92020 |
|
892 |
801 |
$9K |
| 92250 |
|
261 |
219 |
$9K |
| J0178 |
Injection, aflibercept, 1 mg |
20 |
13 |
$3K |
| J9035 |
Injection, bevacizumab, 10 mg |
15 |
12 |
$2K |
| 76514 |
|
25 |
25 |
$275.73 |